Blacksmith Medicines Announces $3.3M in Funding from NIAID to Support Clinical Trial Manufacturing of Novel Antibiotic [Yahoo! Finance]
Cyteir Therapeutics, Inc. (CYT)
Company Research
Source: Yahoo! Finance
targeting metalloenzymes, announced today the release of $3.3M from its contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), Department of Health and Human Services (HHS), to conduct IND-enabling and Phase 1 studies of FG-2101, its novel non-hydroxamate LpxC inhibitor, using both intravenous (IV) and oral administration for the treatment of urinary tract infections caused by multidrug-resistant Gram-negative bacteria. The company's recent successful completion of certain Base Period activities including preclinical toxicology studies triggered the release of this award under its contract with NIAID (75N93022C00060). The total funding could be up to $17.2M over five years, depending on contract options exercised. The new funding will be used for GMP clinical material manufacturing and IND preparation/submission. "With support from NIAID, we have successfully completed preclinical toxicology studies includi
Show less
Read more
Impact Snapshot
Event Time:
CYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYT alerts
High impacting Cyteir Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CYT
News
- Blacksmith Medicines to Present at the Gordon Research Conference on New Antibacterial Discovery and Development [Yahoo! Finance]Yahoo! Finance
- Cyteir Announces Timeline for Voluntarily Delisting from NasdaqBusiness Wire
- Blacksmith Medicines Announces Upcoming Presentation at AACR Annual Meeting 2024 [Yahoo! Finance]Yahoo! Finance
CYT
Earnings
- 5/10/23 - Miss
CYT
Sec Filings
- 3/18/24 - Form POS
- 3/18/24 - Form POS
- 3/18/24 - Form POS
- CYT's page on the SEC website